Clinical Report: Organ Damage, BMI Linked to Fatigue in SLE
Overview
Revise to include a more detailed explanation of how comorbid factors influence fatigue.
Background
Fatigue is a common and debilitating symptom in patients with systemic lupus erythematosus, impacting their quality of life. Understanding the factors associated with fatigue is crucial for improving patient management and outcomes. This study highlights the relationship between fatigue, organ damage, and BMI, providing insights into potential areas for intervention.
Data Highlights
| Group | Mean SLICC/ACR DI | Mean BMI |
|---|---|---|
| With Fatigue (n=95) | 1.9 | 30 |
| Without Fatigue (n=88) | 1.1 | 28 |
Key Findings
- 52% of patients with SLE reported clinically significant fatigue.
- Patients with fatigue had higher organ damage scores (mean SLICC/ACR DI 1.9 vs 1.1).
- Higher body mass index was associated with increased fatigue (mean BMI 30 vs 28).
- No significant correlation was found between fatigue and disease activity scores.
- Fatigue was independently associated with pulmonary fibrosis and neuropathy.
- Racial differences in fatigue reporting were noted, with non-Hispanic White patients reporting higher rates of fatigue.
Clinical Implications
Clinicians should consider assessing organ damage and BMI when evaluating fatigue in SLE patients. Addressing these factors may help improve management strategies for fatigue in this population. Further research is needed to explore the underlying mechanisms of fatigue in SLE.
Conclusion
The study underscores the importance of recognizing the role of organ damage and BMI in the experience of fatigue among SLE patients. Future longitudinal studies are warranted to deepen the understanding of fatigue in this context.
Related Resources & Content
- Marquis Chapman et al., BMJ Open, 2023 -- Organ Damage, BMI Linked to Fatigue in SLE
- Clinical Rheumatology, 2021 -- Adipokine Levels and Metabolic Syndrome in Patients with Systemic Lupus Erythematosus and Systemic Sclerosis
- Clinical Rheumatology, 2023 -- The Relationship Between Dyslipidemia, Inflammation, and Organ Involvement in Systemic Lupus Erythematosus
- Clinical Rheumatology, 2019 -- Changes in Body Composition and Elevated Visceral Fat in Premenopausal and Late Postmenopausal Women with Systemic Lupus Erythematosus
- Clinical Rheumatology, 2022 -- Impact of SARS-CoV-2 on Systemic Lupus Erythematosus: Exploring Endothelial Dysfunction, Atherosclerosis, and Thrombotic Events
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
